# 



## 

|**_Contents_**|**_Pages_**|
|---|---|
|**Legal and administrative information**|**1**|
|**Report of the Trustees**|**2**|
|**Independent examiner's report**|**4**|
|**Statement of financial activities**|**5**|
|**Balance sheet**|**6**|
|**Notes forming part of the financial statements**|**7−12**|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



# 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

|**Statement of financial a**|**ctivities**|**for the year e**|**nded 30 Sep**|**tember 2021**||
|---|---|---|---|---|---|
||||||**Restated**|
||**Notes**|**Unrestricted**|**Restricted**|**Total**|**Total**|
|||**Funds**|**Funds**|**2021**|**2020**|
|||||**£.**|**£.**|
|**Income**||||||
|Donations|3|17,820|−|17,820|9,162|
|Investment income|4|101,728|4,047|105,775|93,802|
|**Total income**||119,548|4,047|123.595|102,964|
|**Expenditure**||||||
|Cost of generating funds:||||||
|Investment managers fees||17,124|552|17,676|17,426|
|Charitable activities:||||||
|Grants payable|6|54,685||54.685|45,586|
|Support costs •|6|32,100|−|32,100|45,280|
|**Total expenditure**||103,909|552|104,461|108,292|
|**Net income (expenditure)**||||||
|**before investment gains**||||||
|**and losses**||15,639|3,495|19,134|(5,a28)|
|Gains and losses on||||||
|revaluations and disposal of||||||
|investment assets|9|536,740|82|536,822|(326,837)|
|**Net income (expenditure)**||||||
|**and net movement in funds**||552,379|3,577|555,956|(332,165)|
|Total funds brought forward||2,924,507|76,208|3,000,715|3,332,880|
|**Total funds carried forward**||3,476,886|79,785|3,556,67t|3,000,71−5|





## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

|||**Unrestricted**|**Restricted**|**Total**|**Total**|
|---|---|---|---|---|---|
|||**Funds**|**Funds**|**2021**|**2020**|
||||**E**|||
|Gift aid|donations|17,820||17,820|9,162|
|||17,820||17,820|9,162|





## 

## 

|**fo**|**r the year ended 30 September 2**|**021 (cont)**||||
|---|---|---|---|---|---|
|**_4._**|**Investment Income**|||||
|||**_Unrestricted_**|**Restricted**|**Total.**|**Total**|
|||**Funds**|**Funds**|**2021**|**2020**|
|||**E**|**E**|**E**|**E**|
||Dividends — Listed investments|101,728|4,047|105,775|93,802|
|||101,728|4,047|105,775|93,802|



## 

|5.|Grants payable|||
|---|---|---|---|
|||**2021**|**2020**|
|||**E**||
||Scholarships|38,982|34,395|
||Beloe fellowship|7,500||
||Dining scholars|2,018|514|
||Assistance to Liverymen|3,410|1,122|
||Service awards and dinners|1,300|2,900|
||General and church grants|1,475|6,655|
|||**54,685**|**45,586**|
|**6.**|**Allocation of support costs**|||
|||**Total**|**Total**|
|||**2021**|**2020**|
|||**E**||
||Fees|||
||Office costs|2,475|7,346|
||Administrative expenses|26,145|34,454|
||Independent examiners fee|3,480|3,480|
|||32,100|45,280|



## 



## 

## 

## 

|**Tangible fixed assets**||
|---|---|
||**Equipment**|
||**fixtures and**|
||**fittings**|
|**Cost:**||
|**At 1 October 2020 and 30 September 2021**|**2,407**|
|**Depreciation:**||
|**At 1 October 2020 and 30 September 2021**|**2,407**|
|**Net book value:**||
|**At 30 September 2021 and 30 September 2020**||



|**9.**|**Investments**||||
|---|---|---|---|---|
||||**2021**|**2020**|
||**Market value at 1 October 2020**||**2,761,766**|**3,116,407**|
||**Additions at cost**||**150,435**|**58,019**|
||**Disposals**||**(133,861)**|**(85,823)**|
||**Net realised and unrealised gain/(loss)**||**536,822**|**(326,837)**|
||**At 30 September 2021**||**3,315,162**|**2,761,766**|
||**Cash in hand**||**244,970**|**249,445**|
||||**3,560,132**|**3,011,211**|
||**Historical Cost as at 30 September 2021**||**2,368,895**|**2,269,016**|
|||**Non UK**|**UK**|**Total**|
|||**£**|**£**|**£**|
||**Investments**|**1,487,845**|**1,827,317**|**3,315,162**|
|**10. **|**Debtors**||||
||||**2021**|**2020**|
||**Other debtors**||**7,199**|**9,975**|
||||**7,199**|**9,975**|





## 

## 

## 

|**Creditors: amounts falling due within one year**|||
|---|---|---|
||**2021**|**2020**|
|||**E**|
|Amounts owed to related undertakings||682|
|Other creditors|17,354|20,132|
||17,354|20,814|



## 

|**Statement of funds**||||
|---|---|---|---|
||**Unrestricted**|**Restricted Funds**||
||**Funds**|**Cohen Fund**|**Total funds**|
||**E**|**E**|**E**|
|Balance at 1 October 2020,|2,924,507|76,208|3,000,715|
|Income|119,548|4,047|123,595|
|Expenditure|(103,909)|(552)|(104,461)|
|Investment gains|536,740|82|536,822|
|Balance at||||
|30 September 2021|3,476,886|79,785|3,556,671|



## 

||**Unrestricted**|**Restricted**|**Total**|**Total**|
|---|---|---|---|---|
||**Funds**|**Funds**|**2021**|**2020**|
||**E**|**E**|**E**|**E**|
|Tangible fixed assets|3,480,347|79,785|3,560,132|3,011,211|
|Current assets|13,893|−|13,893|10,318|
|Creditors: amount|||||
|falling due within one year|(17,354)|−|(17,354)|(20,814)|
||3,476,886|79,785|3,556,671|3,000,715|





# 

## 

##